Clinical Trial

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

Study acronym: COVID-BioB
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2026 (before its estimated June 19, 2026 completion). Its status may not reflect the trial's current state.
Summary
Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2020-03-23; most recent amendment 2026-05-05.
Trial Details
NCT Number NCT04318366
Lead Sponsor Università Vita-Salute San Raffaele
Conditions Coronavirus Infections
Enrollment 6,000 participants
Start Date 2020-03-19
Primary Completion 2026-06-19 (estimated)
Study Completion 2026-06-19 (estimated)
Updated on ClinicalTrials.gov 2026-05-08